The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, epidemiological studies, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), World Health Organization (WHO) Global Health Observatory, American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), American Rhinologic Society (ARS), European Rhinologic Society (ERS), National Institute for Health and Care Excellence (NICE), Agency for Healthcare Research and Quality (AHRQ), IQVIA Institute for Human Data Science, IQVIA MIDAS, Symphony Health Solutions, Definitive Healthcare, and national health ministry reports from key markets including the US, Germany, UK, France, Japan, China, and India. These sources were used to collect disease prevalence statistics, treatment guidelines, regulatory approval data, clinical safety and efficacy studies, antimicrobial resistance patterns, demographic trends, and market landscape analysis for nasal corticosteroids, decongestants, antibiotics, saline nasal sprays, OTC pain relievers, allergy immunotherapy, and diagnostic technologies including nasal endoscopy, CT/MRI imaging, laboratory testing, and allergy diagnostics.
Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consist of CEOs, VPs of Product Development, regulatory affairs chiefs, and commercial directors from pharmaceutical manufacturers, medical device companies, and diagnostic equipment OEMs that specialize in ENT and sinusitis treatments. Demand-side sources included board-certified otolaryngologists (ENT specialists), allergists, infectious disease specialists, hospital pharmacy directors, procurement leads from hospitals and specialty clinics, medical directors of ambulatory surgical centers, and healthcare administrators who administered sinusitis treatment protocols. Market segmentation was validated, product pipeline timelines were confirmed, and market insights regarding clinical adoption patterns, prescribing behaviors, pricing strategies, reimbursement dynamics, and antimicrobial stewardship programs were obtained through primary research.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (33%), Europe (29%), Asia-Pacific (28%), Rest of World (10%)
Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across nasal corticosteroids, decongestants, antibiotics, saline nasal sprays, OTC analgesics, allergy immunotherapy, and diagnostic equipment categories
Analysis of reported and modeled annual revenues specific to acute sinusitis treatment portfolios
Coverage of manufacturers representing 72-78% of global market share in 2024
Extrapolation using bottom-up (treatment volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile").
In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
ケーススタディ
Aerospace & Defense
